NextGen Healthcare Secures Agreement with Renowned Ophthalmology Institution

Wills Eye selects NextGen Healthcare’s integrated platform to facilitate enterprise-wide connectivity and collect quality improvement measures for Meaningful Use

HORSHAM, Pa. (December 16, 2010) – NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and leading provider of healthcare information systems and connectivity solutions, today announced an agreement with Wills Eye Health System to deploy NextGen® Ambulatory EHR and NextGen® Practice Management.

Considered one of the most advanced eye centers in the world, Wills Eye provides the full range of primary and subspecialty eye care, including cataract, cornea, retina and glaucoma treatment, neuro-ophthalmology, oculoplastics, ocular oncology, pediatric ophthalmology, refractive surgery, laser vision correction, diagnostics, low vision services, and emergency room coverage. Based in Philadelphia, Pa., Wills Eye also has a network of multi-specialty ambulatory surgery centers in the tri-state region.

Through this partnership, the NextGen® integrated technology platform will connect the Wills Eye community, giving care providers ubiquitous access to electronic health records and enabling exchange of patient data at the point of care. This level of documentation will help provide the organization with the clinical reporting capabilities needed to demonstrate Meaningful Use.

“Wills Eye was a specialty institution from inception, so we needed a technology partner that could truly understand and support our ophthalmology-specific needs,” said Joseph Bilson, executive director of Wills Eye. “NextGen Healthcare’s long-standing reputation as a leader in the ophthalmology industry was a critical factor in our IT decision. We were also impressed with the company’s commitment to helping us achieve Meaningful Use.”

NextGen Ambulatory EHR features exclusive ophthalmology content, including pre-built clinical templates and workflow, to ensure complete, accurate documentation stored in a standard format. Its disease management templates enable practices to capture discrete data at the point of care

NextGen Practice Management provides reporting capabilities that can be leveraged to track quality improvement measures, a key Meaningful Use requirement. The solution also enables users to optimize reimbursement by automatically comparing fee schedules between allowable codes and patient charge history so they can code and bill for the highest appropriate level of exam, such as comprehensive eye.

“Adding a nationally recognized ophthalmology institution to our client base is further confirmation of our ongoing commitment to this important market,” said Scott Decker, President of NextGen Healthcare. “We look forward to a partnership built upon long-term clinical and financial success and the establishment of a patient-centered care model that sets the standard for other ophthalmology groups to follow.”

For more details on how NextGen Healthcare supports ophthalmology practices and to download case studies, white papers or videos, please visit www.nextgen.com/Specialties/Ophthalmology.

About NextGen Healthcare

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII), provides integrated clinical, financial and connectivity solutions for ambulatory, inpatient and dental provider organizations. For more information, please visit www.nextgen.com and www.qsii.com. Follow NextGen Healthcare on Twitter at www.twitter.com/nextgen or Facebook at http://www.facebook.com/NextGenHealthcare.

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company’s future performance, as well as management’s expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward-looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: volume and timing of systems sales and installations; length of sales cycles and installation process; the possibility that the products will not achieve market acceptance; seasonal patterns of sales and customer buying behavior; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company’s ability or inability to attract and retain qualified personnel; possible regulation of the Company’s software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods’ financial statements; general economic conditions; and the risk factors detailed from time to time in Quality Systems’ periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company’s quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company’s revenues and operating results are very difficult to forecast. A major portion of the Company’s costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company’s period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Patent Pending

Contact
NextGen Healthcare
Kristy DelMuto, 215-657-7010
kdelmuto@nextgen.com

Source: NextGen Healthcare